WellTheory
Autoimmune conditions are rising faster than any other disease, now affecting over 50 million Americans. Yet they remain misunderstood, underdiagnosed, and overlooked. WellTheory is here to change that with a new kind of care that’s personalized, rooted in science, powered by AI, and delivered with compassion. We help people reduce symptoms, feel better, and live fuller lives — while helping employers and payors reduce their spend.
WellTheory raised $14M in a Series A round announced October 24, 2025, according to welltheory.com. Investors in that round: General Catalyst.
Raise history
- First seen by Recent Fundingvia startups.gallery
- Series A · $14M
GGeneral Catalyst (lead)
Source: welltheory.com (startups.gallery listing)
Investors
Related other companies
QQuartermaster$140M · Sep 28, 2026
SSnorkel AI$350M · Sep 23, 2026
EEnveda$311M · Sep 23, 2026
HHeidi Health$100M · Sep 22, 2026FFirecrawl$75M · Sep 22, 2026
CCorridor$25M · Sep 21, 2026- JJack & Jill$40M · Sep 19, 2026
- MMithr Inc.$20M · Sep 19, 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/welltheory.